Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy
Basel, February 13, 2026 – Novartis today announced final results from the…
Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery
Basel, February 6, 2026 – Novartis today broke ground on a new,…